Based on these data, the aim of the present study was to evaluate the association between PTPN22, IL10, OAS2, and CD70 mRNA expression levels with the clinical characteristics and with the serum levels of IL-10, IFN-γ, and IL-17 in SLE patients. The gene discussed is IL17A; the disease is systemic lupus erythematosus.